This video provides a comprehensive microscopic and immunohistochemical guide to diagnosing Merkel cell carcinoma (MCC), an aggressive primary cutaneous neuroendocrine carcinoma. The speaker details its typical clinical presentation in older, sun-exposed individuals and highlights its critical distinction from less aggressive basal cell carcinoma at low power. Key histological features are explained, including the "blue tumor" appearance, absence of basal palisading, characteristic nuclear morphology (fine, dusty chromatin, nuclear molding), and exceptionally high mitotic activity. The video emphasizes the diagnostic utility of immunohistochemistry, particularly Cytokeratin 20 (CK20) with its distinctive perinuclear dot-like pattern, as the primary method to confirm MCC and differentiate it from its main mimicker, metastatic small cell carcinoma of the lung.
Exploring Merkel Cell Carcinoma: A Crucial Diagnosis in Dermatopathology
0:00:06 - Merkel Cell Carcinoma (MCC) Introduction: MCC is an aggressive primary cutaneous neuroendocrine carcinoma typically found in sun-exposed areas of older individuals, known for frequent metastasis and high mortality.
0:00:31 - Low-Power Appearance & Diagnostic Pitfall: At low power, MCC appears as a "blue tumor" filling the dermis. It can be easily mistaken for basal cell carcinoma (BCC), a critical error due to MCC's aggressive nature and different treatment requirements. Always suspect MCC if a dark, cellular, "basaloid" tumor is seen.
0:01:16 - Histological Resemblance: Histologically, MCC shares significant similarities with small cell carcinoma of the lung (SCLC).
0:01:40 - Architectural & Cellular Features: MCC cells are arranged in nests, aggregates, or sheets. A key distinguishing feature from BCC is the lack of basal palisading (nuclei lining up around the periphery of nests).
0:02:16 - Nuclear Morphology: Nuclei exhibit a pale, fine, smudgy, stippled, or dusty chromatin pattern. A hallmark feature is nuclear molding, where nuclei clump and squish together, taking on the shape of neighboring cells rather than remaining perfectly round. Small nucleoli are typical, while large nucleoli are uncommon.
0:04:15 - High Mitotic Activity: MCC is one of the most mitotically active cancers, often displaying an extremely high mitotic rate (e.g., 140 mitoses per 1 mmΒ²), significantly exceeding that of melanomas.
0:05:23 - Immunostain Confirmation with CK20: Immunohistochemistry is crucial for definitive diagnosis. Cytokeratin 20 (CK20) is positive in almost all MCC cases, frequently showing a characteristic perinuclear dot-like ("Golgi") staining pattern. This pattern, combined with classic histology, is highly diagnostic.
0:06:22 - Distinguishing from Metastatic SCLC: Differentiating MCC from metastatic small cell carcinoma of the lung (SCLC) is a primary concern. CK20 is almost always positive in MCC but rarely positive in metastatic SCLC, making it a valuable marker, especially in skin biopsies where MCC is far more common.
0:07:33 - Other Diagnostic Markers: Neurofilament can also present a similar dot-like pattern. Synaptophysin and chromogranin, neuroendocrine markers, are typically positive. TTF-1 (Thyroid Transcription Factor 1), often positive in lung SCLC, can also be positive in MCC; a negative TTF-1 argues against lung SCLC, while a positive result might prompt lung imaging. CK7 is another marker that can stain metastatic SCLC. The speaker primarily relies on CK20 as a first-line stain due to its reliability.